619 related articles for article (PubMed ID: 17628598)
1. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ
J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538
[TBL] [Abstract][Full Text] [Related]
3. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
Murphy GJ; Bicknell GR; Nicholson ML
Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
[TBL] [Abstract][Full Text] [Related]
4. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
5. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof].
Zou HQ; Yao J; Wang YX; Wang J; Li D; Wang P
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):981-5. PubMed ID: 16061007
[TBL] [Abstract][Full Text] [Related]
6. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy.
Neto JS; Nakao A; Toyokawa H; Nalesnik MA; Romanosky AJ; Kimizuka K; Kaizu T; Hashimoto N; Azhipa O; Stolz DB; Choi AM; Murase N
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F324-34. PubMed ID: 16131650
[TBL] [Abstract][Full Text] [Related]
7. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts.
Heemann UW; Azuma H; Tullius SG; Schmid C; Philipp T; Tilney NL
Clin Nephrol; 1996 Jul; 46(1):34-8. PubMed ID: 8832148
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats.
Tan HB; Feng Y; Liu M; Wu YC
Transplant Proc; 2008 Jun; 40(5):1685-9. PubMed ID: 18589173
[TBL] [Abstract][Full Text] [Related]
9. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model.
Lutz J; Huang H; Deng M; Wagner B; Roos M; Schmaderer C; Strobl M; Heemann U
Transplantation; 2007 Mar; 83(6):741-6. PubMed ID: 17414707
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
11. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
12. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U
Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411
[TBL] [Abstract][Full Text] [Related]
13. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
14. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of Hushen Gujing (HSGJ) in preventing chronic allograft nephropathy in rats].
Tian XH; Xue WJ; Wang ZY; Zhou QF; Zhang YS; Ding XM; Tian PX
Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(17):1349-52. PubMed ID: 16323545
[TBL] [Abstract][Full Text] [Related]
17. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model.
Guan Q; Li S; Gao S; Chen H; Nguan CY; Du C
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F199-207. PubMed ID: 23552866
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
[TBL] [Abstract][Full Text] [Related]
20. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
